ERBB2 and gastric neoplasm: Most advanced gastric tumors are negative for human epidermal growth factor receptor 2 (HER2), with the standard first-line chemotherapy for these cases being a two-drug combination of platinum and a fluoropyrimidine, the latter of which is usually oral S-1 or capecitabine in Japan.